Convenience store and gas station operator Yesway (YSWY.US) sets IPO pricing at $20-23 per share, aiming to raise $321 million.
Convenience store and gas station operator Yesway is seeking to raise up to $321 million in its initial public offering (IPO). The company is planning to sell nearly 14 million shares of stock at a price of $20 to $23 per share.
Convenience store and gas station operator Yesway is seeking to raise up to $321 million in its initial public offering (IPO). According to documents submitted to the U.S. Securities and Exchange Commission (SEC) on Monday, the convenience store and gas station operator, which focuses on rural communities in the Midwest and Southwest, plans to sell nearly 14 million shares of stock at a price of $20 to $23 per share. At the upper end of the price range, the company would be valued at around $1.4 billion. The company plans to list on the Nasdaq under the ticker symbol "YSWY".
Supported by Boston private equity firm Brookwood Financial Partners, Yesway had filed for an IPO in 2021 but withdrew the plans the following year due to a substantial closure of the IPO market caused by rising interest rates. Now, amidst ongoing conflicts in the Middle East, Yesway has chosen to move forward with the listing.
The documents show that the company's parent company, BW Ultimate Parent LLC, achieved a net profit of $54 million and revenue of $2.7 billion for the full year 2025, compared to a net profit of $24 million and revenue of $2.5 billion in the previous year. Additionally, the documents also indicate that the recent surge in fuel prices due to the Middle East conflict, coupled with the uncertainty of further increases, may impact Yesway's customers.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






